Baverel P[au] - Search Results

Year	Number of Results
2009	1
2010	1
2011	1
2013	1
2015	1
2017	2
2018	4
2019	2
2020	1
2021	3
2022	3
2023	1
2024	0

1

A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development.

Ruiz-Garcia A, Baverel P, Bottino D, Dolton M, Feng Y, González-García I, Kim J, Robey S, Singh I, Turner D, Wu SP, Yin D, Zhou D, Zhu H, Bonate P. Ruiz-Garcia A, et al. Among authors: baverel p. J Pharmacokinet Pharmacodyn. 2023 Jun;50(3):147-172. doi: 10.1007/s10928-023-09850-2. Epub 2023 Mar 4. J Pharmacokinet Pharmacodyn. 2023. PMID: 36870005 Free PMC article. Review.

2

Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic models.

Truong VT, Baverel PG, Lythe GD, Vicini P, Yates JWT, Dubois VFS. Truong VT, et al. Among authors: baverel pg. CPT Pharmacometrics Syst Pharmacol. 2022 Feb;11(2):133-148. doi: 10.1002/psp4.12703. Epub 2022 Feb 1. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 34399036 Free PMC article.

3

Model enhanced reinforcement learning to enable precision dosing: A theoretical case study with dosing of propofol.

Ribba B, Bräm DS, Baverel PG, Peck RW. Ribba B, et al. Among authors: baverel pg. CPT Pharmacometrics Syst Pharmacol. 2022 Nov;11(11):1497-1510. doi: 10.1002/psp4.12858. Epub 2022 Sep 30. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 36177959 Free PMC article.

4

Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy.

González-García I, Pierre V, Dubois VFS, Morsli N, Spencer S, Baverel PG, Moore H. González-García I, et al. Among authors: baverel pg. CPT Pharmacometrics Syst Pharmacol. 2021 Mar;10(3):230-240. doi: 10.1002/psp4.12594. Epub 2021 Feb 13. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33465293 Free PMC article. Clinical Trial.

5

Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial.

Micallef S, Sostelly A, Zhu J, Baverel PG, Mercier F. Micallef S, et al. Among authors: baverel pg. Contemp Clin Trials Commun. 2022 Feb 5;26:100901. doi: 10.1016/j.conctc.2022.100901. eCollection 2022 Apr. Contemp Clin Trials Commun. 2022. PMID: 35198796 Free PMC article.

6

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status.

Baverel PG, Dubois VFS, Jin CY, Zheng Y, Song X, Jin X, Mukhopadhyay P, Gupta A, Dennis PA, Ben Y, Vicini P, Roskos L, Narwal R. Baverel PG, et al. Clin Pharmacol Ther. 2018 Apr;103(4):631-642. doi: 10.1002/cpt.982. Epub 2018 Feb 2. Clin Pharmacol Ther. 2018. PMID: 29243223 Free PMC article.

7

Dose-Exposure-Response Relationship of the Investigational Anti-Interleukin-13 Monoclonal Antibody Tralokinumab in Patients With Severe, Uncontrolled Asthma.

Baverel PG, White N, Vicini P, Karlsson MO, Agoram B. Baverel PG, et al. Clin Pharmacol Ther. 2018 May;103(5):826-835. doi: 10.1002/cpt.803. Epub 2017 Sep 28. Clin Pharmacol Ther. 2018. PMID: 28758192 Clinical Trial.

8

Exposure-Response Analysis of Overall Survival for Tremelimumab in Unresectable Malignant Mesothelioma: The Confounding Effect of Disease Status.

Baverel P, Roskos L, Tatipalli M, Lee N, Stockman P, Taboada M, Vicini P, Horgan K, Narwal R. Baverel P, et al. Clin Transl Sci. 2019 Sep;12(5):450-458. doi: 10.1111/cts.12633. Epub 2019 Apr 12. Clin Transl Sci. 2019. PMID: 30883000 Free PMC article. Clinical Trial.

9

Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total.

Hood J, González-García I, White N, Marshall L, Dubois VFS, Vicini P, Baverel PG. Hood J, et al. Among authors: baverel pg. Pharmaceutics. 2021 Apr 9;13(4):519. doi: 10.3390/pharmaceutics13040519. Pharmaceutics. 2021. PMID: 33918602 Free PMC article.

10

Association of circulating protein biomarkers with clinical outcomes of durvalumab in head and neck squamous cell carcinoma.

Arends R, Guo X, Baverel PG, González-García I, Xie J, Morsli N, Yovine A, Roskos LK. Arends R, et al. Among authors: baverel pg. Oncoimmunology. 2021 Mar 17;10(1):1898104. doi: 10.1080/2162402X.2021.1898104. Oncoimmunology. 2021. PMID: 33796405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year